ClinConnect ClinConnect Logo
Search / Trial NCT05094297

Evaluating the Impact of Focused Muscle Contraction Therapy in U.S. Veterans

Launched by UNIVERSITY OF ILLINOIS AT CHICAGO · Oct 13, 2021

Trial Information

Current as of August 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at a special exercise program called the GH Method to see if it can help improve the health and well-being of U.S. Veterans who are dealing with issues like chronic pain, fatigue, and depression. The study will involve a total of 94 visits over 18 months, where participants will undergo fitness and health tests at the University of Illinois at Chicago (UIC) and participate in exercise sessions at the GH FITLab. They will also fill out questionnaires about their mental health, including feelings of sadness and stress.

To participate, you need to be a U.S. Veteran receiving care at the Jesse Brown VA Medical Center and experiencing symptoms like pain or low energy. Participants must be at least 18 years old and able to safely engage in the exercise program. It's important to note that those who cannot travel to the training center or understand the study may not be eligible. This trial not only aims to boost physical strength and fitness but also hopes to enhance the overall quality of life for veterans by addressing both physical and mental health challenges.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • U.S. Veterans
  • Eligible subjects must be patients at the Jesse Brown VA Medical Center and suffer from pain, fatigue, low energy levels or are unable to physically do things they were once able to do.
  • Subjects need to complete the PAR-Q with an acceptable score and/or must have written physician clearance.
  • 18 years of age and older
  • Exclusion Criteria:
  • Unable to travel to the training center
  • Unable to give consent
  • Unable to understand the study
  • Unable to comply with the training program

About University Of Illinois At Chicago

The University of Illinois at Chicago (UIC) is a leading academic institution renowned for its commitment to advancing health sciences through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, UIC harnesses the expertise of its diverse faculty and state-of-the-art facilities to conduct cutting-edge clinical studies aimed at improving patient outcomes. The university's robust infrastructure for clinical research, combined with its dedication to ethical standards and regulatory compliance, positions UIC as a pivotal contributor to the development of new treatments and therapies in various medical fields. Through strategic partnerships and community engagement, UIC strives to translate research findings into real-world applications, enhancing the health and well-being of populations locally and globally.

Locations

Chicago, Illinois, United States

Patients applied

0 patients applied

Trial Officials

Enrico Benedetti, MD

Principal Investigator

University of Illinois at Chicago

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials